0 Комментарии
0 Поделились
338 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Intravenous Immunoglobulin Market Explores More Resilient Plasma SourcingThe global intravenous immunoglobulin market was valued at USD 14.9 billion in 2025 and is expected to reach USD 16.0 billion in 2026, rising to USD 25.7 billion by 2033. The market is projected to expand at a 7.0% CAGR from 2026 to 2033. North America accounted for the largest revenue share at 45.9% in 2025, while Asia Pacific is anticipated to register the fastest growth during the forecast...0 Комментарии 0 Поделились 242 Просмотры 0 предпросмотр
-
Intravenous Immunoglobulin Market Growth: Opportunities and Market InsightsThe Intravenous Immunoglobulin Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Intravenous Immunoglobulin Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape, and future...0 Комментарии 0 Поделились 365 Просмотры 0 предпросмотр
-
Intravenous Immunoglobulin Market Trends in ImmunotherapyValued at USD 12.66 billion in 2023, the intravenous immunoglobulin market is projected to reach USD 13.57 billion in 2024 and USD 24.13 billion by 2032, growing at a CAGR of 7.50% during the forecast period 2024–2032. Immunoglobulins, commonly called antibodies, are glycoproteins produced by white blood cells and plasma that detect and bind to antigens such as bacteria and viruses. IVIG...0 Комментарии 0 Поделились 276 Просмотры 0 предпросмотр
-
U.S. Intravenous Immunoglobulin Market Innovations in Plasma ProcessingThe U.S. intravenous immunoglobulin (IVIG) market was valued at USD 5.74 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.7% from 2023 to 2030. Rising demand for immunoglobulin replacement therapy, particularly for primary immunodeficiency diseases (PIDD), and the introduction of new products are supporting market growth. Expanded treatment options,...0 Комментарии 0 Поделились 242 Просмотры 0 предпросмотр
-
U.S. Intravenous Immunoglobulin Market: Demand-Supply Balance Remains VitalThe U.S. intravenous immunoglobulin (IVIG) market was valued at USD 5.74 billion in 2022 and is projected to expand at a 7.7% CAGR from 2023 to 2030. Growth is being supported by increasing demand for immunoglobulin replacement therapy among patients with Primary Immunodeficiency Diseases (PIDD), along with the approval of new IVIG products that are broadening available treatment options. What...0 Комментарии 0 Поделились 357 Просмотры 0 предпросмотр
-
Neonatal Jaundice IVIG Market Size, Trends and Growth- 2032According to the latest report published by Data Bridge Market Research, the Neonatal Jaundice Intravenous Immunoglobulin Market size is projected to grow from USD 24.46 Million in 2024 to USD 39.84 Million by 2032, exhibiting a CAGR of 6.29% during the forecast period 2025 - 2032. Global Neonatal Jaundice Intravenous Immunoglobulin Market document gives important, thoughtful and...0 Комментарии 0 Поделились 481 Просмотры 0 предпросмотр
-
The Role of Contract Manufacturing in Expanding IVIG CapacityThe global intravenous immunoglobulin (IVIG) market was valued at USD 14.9 billion in 2025 and is expected to reach USD 25.7 billion by 2033, expanding at a 7.0% CAGR from 2026 to 2033. The market is projected to increase from USD 16.0 billion in 2026. North America accounted for the largest revenue share at 45.9% in 2025, while Asia Pacific is expected to register the fastest growth during the...0 Комментарии 0 Поделились 224 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek